MANUEL TZAGOURNIS, M.D.; PAUL E. STEFFES, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: The recent article by Drs. Kannel, Castelli, Gordon, and McNamara ("Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease. The Framingham Study." Ann Intern Med 74:1-12, 1971) was an admirable attempt to investigate the importance of prebeta lipoproteins (and, indirectly, triglyceride) in predicting the risk of coronary heart disease. We should like to emphasize, as have the authors, certain shortcomings of data collection concerning the Sf20-400 prebeta lipoprotein data presented. Because of the previously fine quality of work that has come from the Framingham study, some readers may accept the authors' conclusions concerning prebeta lipoproteins perhaps
TZAGOURNIS M, STEFFES PE. Lipoproteins and Coronary Disease. Ann Intern Med. ;74:796–797. doi: 10.7326/0003-4819-74-5-796
Download citation file:
Published: Ann Intern Med. 1971;74(5):796-797.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use